Skip to content

Author

C. Mocerino

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Case report Open access Sep 2026

[Use of sacituzumab govitecan in HR+/HER2- metastatic breast cancer following progression on endocrine therapy and chemotherapy: a case report in line with the results of the TROPiCS-02 study.]

Metastatic hormone receptor-positive HR+/HER2- breast cancer represents the most common biological subtype of advanced breast cancer. Despite the significant improvements achieved with the introduction of CDK4/6 inhibitors combined with endocrine therapy, disease progression eventually occurs in a substantial proportio...

Raffaella Ruocco, Roberto Esposito, Giovanni Fiore et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.